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Antibiotics have played an important role in the treatment of bacteria related infections. 34 
However, the rapid emergence of multidrug-resistant bacteria and limited number of antibiotics 35 
available is a great challenge to humankind. To circumvent the use of antibiotics and hence, 36 
address this problem, we are proposing a photosensitizer-modified biodegradable zeolitic 37 
imidazolate framework-8 nanocomposite that can kill not only Gram-positive bacteria 38 
Staphylococcus aureus, but also methicillin-resistant Staphylococcus aureus with high efficacy. 39 
In vivo testing revealed that these nanocomposites are highly effective for in vivo wound 40 
disinfection with minimal side-effects. In conclusion, this photosensitizer-modified 41 
biodegradable nanocomposite could be very promising for a synergistic antibacterial therapy to 42 
overcome methicillin-resistant Staphylococcus aureus (MRSA). 43 
Keywords: zeolitic imidazolate framework 8; photosensitizer; photodynamic therapy; 44 
antibacterial therapy 45 
 46 
 47 
1. Introduction 48 
Bacterial infection is one of the most prominent causes of serious diseases 1-3. The wide 49 
range and biological variations of pathogenic microorganisms often lead to great 50 
challenges in antimicrobial treatment in clinical settings. With the discovery and 51 
development of antibiotics, the treatment of bacterial infection has been revolutionised4-52 
5. However, long-term abuse and overdose of antibiotics have led to bacterial cells 53 
adversely modifying antibiotic molecules, thereby leading to the emergence of drug-54 
resistant bacteria 6-7. This, in turn, poses a serious public health threat that contributes to 55 
millions of severe infections and even thousands of deaths every year8. According to the 56 
World Health Organisation, more than 700,000 people die worldwide every year from 57 
antibiotic resistant infections and this figure is expected to rise to 10 million a year by 58 




antibiotics, the rate of antibiotic development is still far more behind the high evolution 60 
rate of pathogenic microorganisms. An example is methicillin-resistant Staphylococcus 61 
aureus (MRSA), which was first discovered in England and is considered as one of the 62 
most dangerous clinical pathogens (often known as ‘superbugs’) causing life-threatening 63 
diseases10. Thus, it is crucial that new antimicrobial agents and methods are developed 64 
to mitigate the persistent issue of drug tolerance. One potential solution is to use 65 
nanomaterials for the delivery of antimicrobial agents. The ability of nanomaterials to 66 
allow enhanced localization to bacteria as well as tunable interaction with bacteria upon 67 
surface modification with different charges, roughness, and functional groups can 68 
greatly improve therapeutic properties and efficiency11. Among nanomaterials, metal-69 
organic frameworks (MOFs) have been developed for many biomedical applications12-70 
16. MOFs are constructed using metal ions and organic linker molecules to form 71 
nanoporous materials with many advantages including high surface area, tunable pore 72 
size and porosity, high drug loading capacity, good biocompatibility, potential 73 
biodegradability, and greater flexibility in the selection of organic and inorganic 74 
components17-19. Therefore, several MOFs with different functionalities have been 75 
successfully designed for antibiotic and silver loading for increased antibacterial 76 
efficacy20-22. Liu and co-workers have reported the use of MIL-100 (Fe) MOFs as a 77 
nanocarrier to deliver the metabolic labelling molecule 3-azido-D-alanine for precise 78 
bacterial detection and fluorescence image-guided therapy23. Beyond these applications 79 
of using MOFs, we herein propose an integrated multifunctional nano MOF (NMOFs) 80 
system based on zeolitic imidazolate framework-8 (ZIF-8) for antibacterial applications 81 
(Figure 1). Photodynamic therapy (PDT) is widely utilized for biomedical applications 82 
including cancer therapy, wound healing and disinfection.24-26 This technique makes use 83 
of light excitation to generate reactive oxygen species (ROS) to directly attack and kill 84 




pathogenic bacteria and its generation has been found to be very promising in the 86 
endeavour to solve the antibiotic resistance problem29. To achieve a nanocomposite 87 
capable of photodynamic therapy, the photosensitiser, Chlorin e6 (Ce6) was chosen 88 
because of its low dark toxicity and high efficacy. Furthermore, Ce6 was selected over 89 
other photosensitising drugs as it can be easily attached on the surface of the ZIF-8 via 90 
an intermediate conjugation step with APTES and then mixing with the ZIF-8 solution. 91 
Secondly, in our proposed hybrid structure, the Zn2+ ions act as a toxin for the inhibition 92 
of bacterial growth30. Third, the nanoparticles possess a rough surface which has been 93 
demonstrated to drastically influence the interaction with bacterial cells, thereby 94 
achieving high antibacterial efficacy31-33. Finally, the soft-template based NMOFs are 95 
pH-sensitive and easiliy decompose in a weak acid environment compared to other 96 




Figure 1. Schematic illustration of Ce6 doped ZIF-8 nanoparticles fabrication and their use 101 





2. EXPERIMENTAL SECTION 104 
2.1 Chemicals and Characterization. 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide 105 
(EDC), 2-methylimidazole (linker) and 1, 3-diphenylisobenzofuran (DPBF) were purchased 106 
from Damas-beta. Zinc nitrate hexahydrate (Zn(NO3)2·6H2O) and poly(acrylic acid, sodium 107 
salt) (PAAS) were from Strem and Sigma-Aldrich, respectively. Methyl alcohol, ethyl alcohol, 108 
isopropyl alcohol and absolute ethyl alcohol, were purchased from General-Reagent, China. (3-109 
aminopropyl) triethoxysilane (APTES) and Chlorin e6 (Ce6) were ordered from J&K and 110 
Frontier Scientific, respectively. Transmission electron microscopy (TEM) images were taken 111 
on a Tecnai G2 F20 S-TWIN. The UV−VIS absorption spectrum was determined with a UV-112 
1900PC UV−visible spectrophotometer. Powder X-ray diffraction (XRD) patterns, Fourier 113 
transform infrared spectroscopy (FT-IR) and X-ray photoelectron spectroscopy (XPS) were 114 
recorded using a BRUKER D8 instrument with Cu Kα radiation, Nicolet IS10 and Thermo 115 
escalab 250Xi, respectively. The L13152 InvitrogenTM Molecular ProbesTM LIVE/DEAD® 116 
BacLight Bacterial Viability Kit was obtained from Thermo Fisher Scientific. 117 
2.2 Preparation of APTES Conjugated Ce6. 1 mg of Ce6 and 20 μL of APTES were added 118 
to 1 mL of ethyl alcohol in the presence of EDC as a catalyst and magnetically stirred for 24 h 119 
at room temperature. 120 
2.3 Preparation of ZIF-8 and Ce6 doped ZIF-8. First, 50 μL of 200 μg/mL PAAS were added 121 
to 1.5 mL of H2O, then 6 mL of isopropyl alcohol was added in a dropwise manner. 0.1M Zn2+ 122 
solution was prepared by dissolving Zn(NO3)2·6H2O in methyl alcohol and 1.25 mL of the 0.1 123 
M Zn2+ was quickly added to the liquid mixture and stirred for 5 min at room temperature. 2.5 124 
mL of 20 mg/mL 2-methylimidazole dissolved in methyl alcohol was then injected into the 125 
mixture and kept stirring for 4 h at 60oC. The solution was subsequently cooled and precipitated 126 
by centrifugation at 6000 rpm for 10 min. The resulting solid was washed with absolute ethyl 127 
alcohol and water thrice. The sediment was then dispersed into 5 mL of 50% ethyl alcohol. 128 




24 h. After the reaction, the product was washed with ethyl alcohol and water thrice and then 130 
dried in a vacuum to yield Ce6 doped ZIF-8. 131 
2.4 Singlet Oxygen Generation Ability Analysis. 2.82 mL of 0.05 mg/mL DPBF solution in 132 
dimethyl sulfoxide (DMSO) was added into a quartz colorimetric dish. 0.18 mL of free Ce6 or 133 
Ce6 doped ZIF-8 containing 900 ng of Ce6 was added to different individual dishes. The dishes 134 
were then irradiated with a 650 nm LED lamp. After irradiation, the absorbance of the sample 135 
in each dish was measured at 410 nm using a UV-1900PC UV−visible spectrophotometer. 136 
2.5 Antibacterial Test. Staphylococcus aureus (S. aureus) and MRSA were chosen as bacterial 137 
models to evaluate the antibacterial activity. The bacterial concentration in Lysogeny broth 138 
(LB) was maintained at about 106 CFU mL-1 and cultured at 37oC in an incubator-shaker. 139 
Corning 96-well plates were used for this test. Four pre-determined concentrations of 140 
nanoparticles were prepared in milli-Q water and these  were added to the bacterial suspension 141 
in a 1:1 ratio and then incubated. For the groups being treated with light, the Corning 96-well 142 
plates were exposed to 650 nm LED light for 30 minutes at an intensity of 150 (100x LUX) 143 
before incubation at 37 oC for 12 h. The bacterial inhibition growth curve was determined by 144 
measuring the optical density at 600 nm at 2 h time intervals over the 12-h period. 145 
2.6 Live-Dead Imaging. The antibacterial effect of Ce6-doped ZIF-8 nanoparticles and LED 146 
light irradiation were demonstrated using Live/Dead Imaging. Staphylococcus Aureus was used 147 
as the model bacteria. Four treatment groups were considered namely, bacteria without light 148 
irradiation (A), bacteria with light irradiation (B), nanoparticles treated with bacteria but 149 
without light irradiation (C) and nanoparticles treated with bacteria with light irradiation (D). 150 
10 µL from a Staphylococcus Aureus (USA300) stock was cultured overnight on LB agar at 151 
37℃ for 18 h. A single colony was then inoculated in liquid LB media and grown overnight at 152 
37 °C with shaking at 200 rpm. The overnight culture was then diluted (1:100) and the sample 153 
incubated until an optical density of ~0.5 at 600 nm was reached. PBS was then used to wash 154 




media was added to the bacteria and then serially diluted to adjust the optical density to 0.05 156 
(~106 CFU mL-1). A stock solution of the Ce6-doped ZIF-8 nanoparticles dispersed in milli-Q 157 
water was prepared at a concentration of 1 mg/mL. Then, a 5 mL solution with a concentration 158 
of 22.2 μg/mL from this stock solution was prepared and sonicated for 20 mins for an even 159 
nanoparticle dispersion. 1 mL of this solution was added to 1 mL of the bacterial culture (for 160 
conditions C and D) in a sterile 6-well plate. The bacterial suspension for conditions A and B 161 
were left untreated and 1 mL of PBS was added as  a control. The plate was then incubated at 162 
37℃ for 2 hours in the dark with shaking. After 2 hours, the wells containing bacteria from 163 
conditions B and D were exposed to a 650 nm LED light source for 30 minutes placed at a 164 
vertical height of 22 cm from the plate. The plate was then further incubated for 2 hours at 37℃ 165 
with shaking. After incubation, a 1:1000 dilution was carried out with each of the four samples 166 
and 100 µL of the diluted solution was plated for CFU determination. The remaining solution 167 
in each well was transferred into 2 mL Eppendorf tubes, washed thrice with PBS by 168 
centrifugation at 15000 rpm for 5 mins and then re-suspended in 500 µL of PBS. The four 169 
samples were then stained by adding an equal amount of PI/Syto9 dye mixture prepared as per 170 
the manufacturer’s instructions. The stained bacterial suspensions were then incubated in the 171 
dark for 15 minutes. To remove excess dye, each sample was washed with PBS thrice by 172 
centrifugation at 20000 rpm for 5 mins and then finally resuspended in 200 μL of PBS. 20 μL 173 
of each of this stained bacterial suspension was trapped between a slide and a 25 mm diameter 174 
round coverslip. The edges of the coverslip were sealed, and the samples observed in a Zeiss 175 
LSM 880 with Fast Airyscan confocal microscope. 176 
2.7 Animal Wound Infection Model and Histological Analysis. All the procedures were 177 
carried out in accordance with the guidelines issued by Chengdu University and Sichuan 178 
Province. All the experiments were approved by the Animal Ethics Committee of Chengdu 179 




developed at the dorsal side of each mouse. After 24 h, the wounds were infected with S. aureus 181 
and then treated with the Ce6 doped ZIF-8 nanoparticles. The light treated group of mice was 182 
exposed to 650 nm LED light for 30 mins. At day 17, all mice were sacrificed. The heart, liver, 183 
spleen, lung, kidney, and wound were harvested and the tissues fixed in a 10% formalin solution, 184 
embedded in paraffin, sectioned, and stained. All the samples were subsequently processed for 185 
hematoxylin and eosin (H&E) staining.  186 
3. RESULTS AND DISCUSSION 187 
Nanoscale ZIF-8 was fabricated using poly(acrylic acid sodium salt) (PAAS) nanosphere as a 188 
soft template.34-35 Since Zn2+ has a higher affinity towards the –COO- group in the PAAS 189 
polymer chain, it was absorbed on the PAAS and thus, replaced the Na+. Then, 2-190 
methylimidazole (2-MIMs) was added and reacted with the Zn2+ on the surface to form ZIF-8 191 
nanocrystal on the PAA nanosphere. Next, (3-aminopropyl) triethoxysilane (APTES) 192 
conjugated Ce6 was reacted with the nanocomposite for drug conjugation. The ZIF-8 193 
nanocomposite has a diameter of approximately 50-90 nm and (Figure 2 and Figure S1) the 194 
Ce6 loading in the nanocomposite is 4.5 wt% (Figure 2 and Figure S1). As illustrated in Figure 195 
3A, the fabricated nanocomposite has XRD peaks identical to ZIF-8, confirming successful 196 
formation of ZIF-8 crystal structure. The Fourier transform infrared (FT-IR) spectrum of the 197 
nanocomposite contains Ce6 peaks, establishing the successful conjugation of Ce6 (Figure 3B). 198 
In addition, the X-ray photoelectron spectroscopy (XPS) confirms the existence of Zn and Si 199 
elements in the nanoparticles with a weight atomic ratio of 8.58% and 4.11%, respectively. 200 










Figure 3 A. Powder X-Ray diffraction pattern, B. Fourier transform infrared spectroscopy and 208 
C. XPS analysis of Ce6 doped ZIF-8 nanoparticles. 209 
 210 
Next, the optical properties of the Ce6 doped ZIF-8 were evaluated. Figure 4A shows the 211 
absorbance spectra of Ce6 doped ZIF-8 nanocomposite and free Ce6 molecules, it is apparent 212 
that the spectra are similar but with a shift in absorbance of the peaks. We then investigated the 213 
photo-stability of the Ce6 doped ZIF-8 when exposed to light (Figure 4B and Figure S2), it was 214 
found that the absorbance intensity of free Ce6 molecules dramatically decreases after a short 215 




nanocomposite is much more stable. Next, a fluorescence probe, 1, 3-diphenylisobenzofuran 217 
(DPBF), was used to detect singlet oxygen molecules and study the ROS generation capacity 218 
of the Ce6 doped ZIF-8 nanoparticles. Under 650 nm LED light irradiation, both free Ce6 219 
molecules and Ce6 doped ZIF-8 can effectively generate singlet oxygen (Figure 4C). To further 220 
study the photo-stability of the Ce6 doped ZIF-8 nanocomposites, their ROS generation 221 
capacity was investigated after light exposure. Both Ce6 doped ZIF-8 and Ce6 molecules were 222 
initially exposed to 650 nm LED light for 30 minutes and then the formation of ROS from each 223 
material was studied. As presented in Figure 4D, free Ce6 molecules lose the majority of their 224 
ROS generation capacity after light exposure as indicated by the small decrease in rate of the 225 
absorbance of DPBF, while the Ce6 doped ZIF-8 can still generate ROS, thereby resulting in a 226 
substantial decrease of the absorbance of DPBF. Next, we tested the biodegradability of 227 
fabricated Ce6 doped nanoscale ZIF-8 in a weak acid environment. As shown in Figure S3, the 228 
nanocomposite is biodegradable in a weak acid environment and loses its whole structure within 229 






Figure 4. Optical properties and singlet oxygen generation capacity of Ce6 doped ZIF-8 233 
nanoparticles. A. Absorption spectra of Ce6 doped ZIF-8 and free Ce6 molecules. B. 234 
Normalized 400 nm absorbance intensity change of Ce6 doped silica and free Ce6 caused by 235 
650 nm LED irradiation. C-D. Absorbance spectra of DPBF with the addition of Ce6 doped 236 
silica and free Ce6 under LED illumination. (C) Degradation in intensity when DPBF added 237 
with Ce6 doped silica and free Ce6, (D) Degradation in intensity when Ce6 doped silica and 238 
free Ce6 were illuminated under 650 nm LED light  for 30 min before addition of DPBF. Data 239 
in B-D are expressed as mean ± s.d. (indicated by error bars), based on values obtained from 240 
three replicates (n=3). 241 
 242 
The antibacterial performance of Ce6 doped ZIF-8 was subsequently analyzed with S. aureus 243 
and MRSA as model bacteria (Figure S4 and Figure 5). The growth of bacteria in liquid media 244 
was monitored by measuring the optical density of Luria-Bertani (LB) broth at a wavelength of 245 
600 nm. At first, the influence of light irradiation on bacterial growth was excluded by 246 
comparing the growth of bacteria with and without light illumination. It was found that the 247 
bacterial growth with and without light illumination was nearly identical, suggesting that the 248 
light at the used power does not inhibit bacteria growth. At a concentration of 200 μg/mL, the 249 
Ce6 doped ZIF-8 nanoparticles could effectively inhibit the growth of S. aureus and MRSA 250 
irrespective of light illumination. This indicates that the Ce6 doped ZIF-8 nanoparticles are 251 
toxic to bacteria; the toxicity originates from the Zn2+ ions within the material, as Ce6 cannot 252 
kill bacteria in the absence of light illumination. When the concentration was decreased to 66.7 253 
μg/mL, the Ce6 doped ZIF-8 nanoparticles partially inhibited the growth of bacteria in the 254 
absence of light irradiation. In comparison, Ce6 doped ZIF-8 nanoparticles at the same 255 
concentration could effectively inhibit the growth of both MRSA and S. aureus upon light 256 
irradiation. This demonstrates that the photo-toxicity of the Ce6 doped ZIF-8 is also responsible 257 
for bacterial growth inhibition. To confirm this observation, we further dropped the 258 
concentration of the Ce6 doped ZIF-8 nanocomposite to 22.2 and 7.4 μg/mL and found that the 259 
Ce6 doped ZIF-8 nanoparticles were still able to completely inhibit S. aureus and MRSA 260 
growth in the presence of LED light. This finding was also confirmed when the plate count 261 




of <<0.05 which showed a significant difference between the ZIF-Ce6 nanoparticles and light 263 
group and any other group at the 12 h time point for all 4 tested concentrations. Overall, the 264 
Ce6 doped ZIF-8 nanoparticles exhibited excellent light-induced antibacterial performance. 265 
 266 
Figure 5. Anti-MRSA performance of Ce6 doped ZIF-8 with different concentrations: A. 200 267 
µg/mL, B. 66.7 µg/mL, C. 22.2 µg/mL and D. 7.4 µg/mL. Control means only LB added. “+” 268 
indicates with light illumination; “-” indicates without light illumination. All data are expressed 269 
as mean ± s.d. (indicated by error bars), based on values obtained from six biological replicates 270 
(n=6). 271 
After demonstrating the antibacterial ability of Ce6-doped ZIF-8 nanoparticles by measuring 272 
the optical density and counting the CFU number of bacteria, we continued this investigation 273 
using confocal fluorescence microscopy imaging. We performed Live/Dead bacterial staining 274 
using the L13152 InvitrogenTM Molecular ProbesTM BacLight™ Bacterial Viability Kit. The 275 
Syto9 dye stains bacteria with both intact membranes and damaged membranes while the 276 
propidium iodide dye penetrates only the bacteria with damaged membranes. As evidenced by 277 
the confocal images in Figure 6, a low concentration of Ce6-doped ZIF-8 nanoparticles (22.2 278 




nanoparticles at the same concentration and light irradiation, nearly all bacteria are killed. This 280 
is in line with the above results obtained by CFU plating and optical density measurements. 281 
The synergistic effect shown in these experiments demonstrates the potent efficacy of the 282 
proposed combined therapy and implies that nanoparticles at very low concentrations can still 283 
yield effective antibacterial efficiency. 284 
 285 
Figure 6. Live/dead staining of S. aureus treated with Ce6-doped ZIF-8 nanoparticles in the 286 
absence of light (Light -) (a-c) and presence of light irradiation (light +) (d-f). Scale bars indicate 287 
5 μm. The concentration of Ce6-doped ZIF-8 nanoparticles used for imaging was 22.2 µg/mL. 288 
 289 
Finally, it is important to determine if this technique could be potentially used in clinical 290 
applications. Thus, the in vivo anti-infection performance of Ce6 doped ZIF-8 nanoparticles 291 
was evaluated using a Balb/c mouse model. A wound was created on the back of mice followed 292 
by infection with S. aureus bacteria. (Figure 7) The mice were then randomly divided into four 293 
groups. One group of mice was treated with free Ce6 molecules and irradiated with light. Two 294 
groups of mice were treated with Ce6 doped ZIF-8 nanoparticles (one with light irradiation and 295 
the other without light irradiation). Another group of mice were used as a control and not 296 




different treatment conditions. A clear difference in wound morphology after treatment was 298 
observed. It is apparent that the wounds treated by the Ce6 doped ZIF-8 nanoparticles with light 299 
irradiation show a better recovery pattern than other groups. Wounds like the ones introduced 300 
in this experiment have a general tendency to be alkaline and slowly turn acidic as wound 301 
healing is initiated.36 As the ZIF-8-Ce6 nanocomposites are responsive to acidic pH, their 302 
dissociation within the wound environment could enhance their antibacterial function while 303 
being finally cleared. Haemotoxylin and Eosin (H&E) analysis of wound harvested from mice 304 
treated with both Ce6 doped ZIF-8 and light irradiation reveals a complete and intact skin 305 
structure. In addition, no obvious abnormality was found in the major organs of the mice treated 306 
with the Ce6 doped ZIF-8 nanoparticles and light irradiation.(Figure S7) During the whole 307 
experimental period, no obvious change in body weight was found in all groups (Figure 7B). 308 
Collectively, these observations demonstrate the robust wound healing efficiency and good 309 
biocompatibility of the synthesized Ce6-doped ZIF-8 nanoparticles. 310 
 311 
Figure 7. In vivo antibacterial evaluation of S. aureus infected wound treated with Ce6 doped 312 
ZIF-8. A. Digital images of S. aureus infected wound treated with different drug formations. B. 313 
Body weight of mice treated in different groups. Data are expressed as mean ± s.d. (indicated 314 
by error bars). C. Haematoxylin and Eosin stain of S. aureus infected skin tissue sections treated 315 




4. Conclusion 317 
In conclusion, our study illustrates a strategy for the synthesis of Ce6 doped ZIF-8 318 
nanoparticles for enhanced antibacterial applications,  with a strong potential for killing 319 
bacteria with multi-drug resistance. The conjugation of Ce6 to ZIF-8 nanoparticles could 320 
significantly improve the photostability and ROS generation capacity of free Ce6 321 
molecules. Our in vitro testing and live/dead imaging demonstrates the excellent 322 
synergistic therapeutic efficacy of the Ce6-doped ZIF-8 nanoparticles against S. aureus 323 
and MRSA. The in vivo wound healing studies on S. aureus infected mice further 324 
confirmed the highly effective  antibacterial performance and good biocompatibility of 325 
the nanoparticles and thus, warrants their future applications in clinical settings.  326 




Appendix A. Supplementary data 331 
 332 
Supplementary material (SEM images, time-dependent morphology and absorbance changes, 333 
bacterial colony-forming units, hematoxylin and eosin stain images) related to this article can 334 
be found, in the online version, at doi: 335 
 336 
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